Two Cannabis Scientists get Nerdy: Genetics & Plant Chemistry

Dr. Riley Kirk welcomes Dr. Anna Schwabe to the Bioactive Podcast for a deep dive into cannabis genetics, cultivar identity, plant chemistry, and the challenges of making sense of cannabis in a rapidly evolving industry. As two cannabis scientists get thoroughly nerdy, they explore the relationship between genetics and chemical expression, why cultivar names matter, and what science can and cannot tell us about predicting cannabis effects.

Drawing from years of research in cannabis genomics, chemotypes, and consumer behavior, Anna explains the disconnect between strain names, marketing claims, and actual genetic identity. The conversation examines how genetics, environment, cultivation practices, and post-harvest handling influence the final chemistry of a cannabis product, often making consumer expectations difficult to predict.

They also explore the limitations of the indica, sativa, and hybrid framework, discussing why these categories may still serve a purpose for new consumers while highlighting the need for more nuanced approaches to cannabis classification. The discussion dives into terpene science, aroma-based selection, cultivar verification, consumer perception, breeding strategies, and the future of genetic authentication in cannabis.

Additionally, Riley and Anna tackle common industry misconceptions, the importance of preserving cannabis history and culture, and how science can help bridge the gap between growers, consumers, researchers, and retailers. Throughout the episode, they emphasize practical ways consumers can make better decisions while exploring the fascinating complexity of cannabis chemistry and genetics.

Whether you're a grower, breeder, budtender, researcher, medical patient, or curious consumer, this episode offers valuable insights into how cannabis genetics shape the products we use and the experiences we have.

CHAPTERS:

00:00 Podcast Crossover Intro

01:38 New Mom Conference Life

02:32 Cannabis on Social Media

03:59 Schedule III Debate

06:36 Pharma Versus Whole Plant

10:08 Synthetic THC And Isomers